New comment by nik_s in "Pill to treat pancreatic cancer hailed as 'biggest breakthrough in decades'"

I think the layman's perception of the increase in survival (~13 months versus ~6 months) will make this look underwhelming. Nevertheless, it's important to remember that the incentives for clinical trials is to only include very late-stage patients who have exhausted all other options (faster trials, smaller sample sizes, surrogate endpoints, a shot at accelerated approval, ...). The fact that a treatment shows promise for these patients that are often in very poor health and considered "hopeless" by today's medicine is exceedingly rare, and the signal from this trial is indeed strong.The (somewhat reasonable) hope is that patients 1. with earlier forms of pancreatic cancer (non-metastatic) 2. that can undergo surgery 3. together with a (neo)adjuvant treatment with these kras inhibitors, will end up having a much lower recurrence rate and a chance for a long, healthy life.I think this is genuinely good news worth celebrating!
Take Your Experience to the Next Level
NewDownload our mobile app for a faster and better experience.
Comments
0U
Join the discussion
Sign in to leave a comment